Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

bamlanivimab and etesevimab drug combination MeSH Supplementary Concept Data 2025


MeSH Supplementary
bamlanivimab and etesevimab drug combination
Unique ID
C000717627
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000717627
Entry Term(s)
LY-3819253 and LY-CoV016
LY-COV555 and LY-CoV016
bamlanivimab and etesevimab
bamlanivimab plus etesevimab
bamlanivimab, etesevimab drug combination
bamlanivimab-etesevimab
Registry Numbers
0
Heading Mapped to
*Antibodies, Monoclonal
Drug Combinations
*Antibodies, Neutralizing
Frequency
9
Note
a mixture of anti-SARS-Cov-2 antibodies
Indexing Information
COVID-19
Date of Entry
2021/06/04
Revision Date
2021/12/09
bamlanivimab and etesevimab drug combination Preferred
LY-COV555 and LY-CoV016 Narrower
page delivered in 0.004s